ZhilianhaiAccuray Incorporated: CyberKnife Robotic Radiation Therapy
Company and clinical technology
Accuray Incorporated supplies radiation treatment technology, including the CyberKnife platform. CyberKnife belongs in a medical robotics evaluation because radiation delivery is robotically positioned; it is not a laparoscopic surgical arm. The current CyberKnife page identifies the S7 generation and provides a route into the company's radiosurgery offering.
What the proposed system must cover
Accuray describes CyberKnife S7 as a robotic system for noninvasive radiosurgery. Its broader portfolio also includes Radixact and TomoTherapy technologies. A buyer should identify the treatment-delivery platform, planning software, imaging functions and data-management components separately. Features advertised for another Accuray platform should not be assumed to be part of a CyberKnife quotation.
A country-specific regulatory milestone
On January 13, 2025, Accuray announced Chinese NMPA approval of CyberKnife S7 and Radixact SynC. These are distinct named systems in a specific market. The release supports a dated account of China's product portfolio; it does not establish approval for every configuration or clinical use worldwide. Request current local registration and labeling for the proposed purchase.
Clinical workflow and accountability
A departmental evaluation should involve radiation oncology, medical physics, treatment staff, information technology and facilities engineering. Map the workflow from imaging and treatment planning through plan checks, patient setup, delivery and documentation. Identify which information moves between systems, who authorizes each step and how the team responds when treatment cannot proceed as planned.
Clinical suitability, treatment selection and follow-up remain professional decisions. The technology description should not be used to promise a fixed number of sessions, a particular outcome or suitability for an individual patient.
Facility and commissioning scope
Before comparing commercial offers, request the complete installation requirements for the selected configuration. The specification should address room design, utilities, equipment access, network connections, installation responsibilities and commissioning support. Agree who provides acceptance equipment and documentation, and how the clinical team signs off the system before routine use.
Build the schedule around the institution's actual readiness. An equipment delivery date is different from completion of installation, technical acceptance, staff training and authorization to treat patients.
Evidence and lifecycle costs
Manufacturer materials explain system positioning and intended capabilities. Comparative clinical and economic claims require review of their underlying evidence, patient populations and operating assumptions. For a business case, separate equipment and software acquisition from service, upgrades, staff development, quality assurance and facility work. Ask whether proposed software functions depend on additional licenses or supporting hardware.
International contact and support
Accuray's official contact page is the commercial starting point. Provide the country, institution, current treatment infrastructure and proposed clinical program. Request the responsible sales entity, authorized local support, training language and service arrangements. A multinational product presence does not establish identical configurations, contractual terms or spare-parts availability in every territory.
Questions for a purchasing brief
Which CyberKnife generation and software modules are included?
What local indication and configuration documentation applies?
Who owns room readiness, installation, commissioning and training?
What service, upgrade and data-interface commitments extend beyond delivery?
Continue with Medical and Rehabilitation Robots, Write a Robotics Buyer Brief, or Robotics RFQ.